Replies to post #206 on Equity Field Notes from temporal sources

[DanWebzster]

CCEL is a private umbilical cord blood and tissue bank

It derives revenue from processing and storage fees. The annual storage fee is $150/yr. These recurring fees account for 50-60% of revenue.

CCEL started to consolidate this industry by recently acquiring on the highest quality cord banks in the USA

Presently, only 2.6% of U.S. births participate in cord storage. CCEL captures about 4.5% of these participants.

Trading in this issue is quite thin. The best way to invest in this stock may be to set a limit order at an objective value such as 15x EV/EBIT